Literature DB >> 16106363

Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses.

Linh H Vong1, Michael J Ragusa, John J Schwarz.   

Abstract

Mef2c belongs to the myocyte enhancer factor 2 (MEF2) family of MADS-box containing transcription factors, which have been shown to be important for various processes involved in cell differentiation, cell survival, and apoptosis. Previous gene-targeting studies have demonstrated a role for mef2c in early heart development since mice lacking mef2c die at embryonic day 9.5 due to cardiac and vascular defects. Since the early embryonic lethality of mef2c prevents an examination of its role in the later stages of heart development, conditional mef2c(loxP/loxP) mice were generated to allow for temporal- and tissue-specific analyses. We report here that general Cre recombinase-mediated removal of the second coding exon of mef2c phenocopied the original mef2c null. Additionally, myocardial-specific removal of mef2c resulted in viable offspring, demonstrating that while mef2c is required for the early development of the heart, it is not necessary for the formation of the heart after looping morphogenesis. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106363     DOI: 10.1002/gene.20152

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  35 in total

Review 1.  Enhancer identification through comparative genomics.

Authors:  Axel Visel; James Bristow; Len A Pennacchio
Journal:  Semin Cell Dev Biol       Date:  2007-01-05       Impact factor: 7.727

Review 2.  Epigenetics and autosomal dominant polycystic kidney disease.

Authors:  Xiaogang Li
Journal:  Biochim Biophys Acta       Date:  2010-10-20

3.  Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c.

Authors:  Sandra Stehling-Sun; Jessica Dade; Stephen L Nutt; Rodney P DeKoter; Fernando D Camargo
Journal:  Nat Immunol       Date:  2009-01-25       Impact factor: 25.606

4.  Therapeutic Engagement of the Histone Deacetylase IIA-Myocyte Enhancer Factor 2 Axis Improves Experimental Pulmonary Hypertension.

Authors:  Avraham Sofer; Seyoung Lee; Irinna Papangeli; Takaomi Adachi; Cheol Hwangbo; Suzy Comhair; Paul DaSilva-Jardine; Jongmin Kim; John J Schwarz; Serpil C Erzurum; Hyung J Chun
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 21.405

5.  The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10.

Authors:  Pooja Agarwal; Michael P Verzi; Thuyen Nguyen; Jianxin Hu; Melissa L Ehlers; David J McCulley; Shan-Mei Xu; Evdokia Dodou; Joshua P Anderson; Maria L Wei; Brian L Black
Journal:  Development       Date:  2011-06       Impact factor: 6.868

6.  Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts.

Authors:  Sheng Xia; Xiaogang Li; Teri Johnson; Chris Seidel; Darren P Wallace; Rong Li
Journal:  Development       Date:  2010-02-24       Impact factor: 6.868

Review 7.  Understanding Heart Field Progenitor Cells for Modeling Congenital Heart Diseases.

Authors:  Matthew Miyamoto; Harshi Gangrade; Emmanouil Tampakakis
Journal:  Curr Cardiol Rep       Date:  2021-03-11       Impact factor: 2.931

8.  Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c.

Authors:  Matthew J Potthoff; Michael A Arnold; John McAnally; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

9.  Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury.

Authors:  Archana Vijayakumar; Nicholas J Buffin; Emily J Gallagher; Jeffrey Blank; Yingjie Wu; Shoshana Yakar; Derek LeRoith
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

10.  Multiple organ system defects and transcriptional dysregulation in the Nipbl(+/-) mouse, a model of Cornelia de Lange Syndrome.

Authors:  Shimako Kawauchi; Anne L Calof; Rosaysela Santos; Martha E Lopez-Burks; Clint M Young; Michelle P Hoang; Abigail Chua; Taotao Lao; Mark S Lechner; Jeremy A Daniel; Andre Nussenzweig; Leonard Kitzes; Kyoko Yokomori; Benedikt Hallgrimsson; Arthur D Lander
Journal:  PLoS Genet       Date:  2009-09-18       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.